APO Research

APO RESEARCH · REPORT

Naoliqing Capsules

Selected research

Industry Growth & Trends

Global Naoliqing Capsules Industry Growth and Trends Forecast to 2032

Market perspective

The global Naoliqing Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Naoliqing Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Naoliqing Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Naoliqing Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Naoliqing Capsules include Xiuzhen Pharmaceutical Group Co., Ltd., Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd., Tonghua Xindongri Pharmaceutical Co., Ltd., Shanxi Tiansheng Pharmaceutical Co., Ltd., Shanxi Yellow River Chinese Medicine Co., Ltd., Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd., Shanxi Huakang Pharmaceutical Co., Ltd., Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. and Jilin Zixin Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Naoliqing Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Naoliqing Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Naoliqing Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Naoliqing Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Naoliqing Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Naoliqing Capsules Market by Company

Xiuzhen Pharmaceutical Group Co., Ltd.

Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.

Tonghua Xindongri Pharmaceutical Co., Ltd.

Shanxi Tiansheng Pharmaceutical Co., Ltd.

Shanxi Yellow River Chinese Medicine Co., Ltd.

Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.

Shanxi Huakang Pharmaceutical Co., Ltd.

Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.

Jilin Zixin Pharmaceutical Co., Ltd.

Jilin Yinok Pharmaceutical Co., Ltd.

Jilin Tiantai Pharmaceutical Co., Ltd.

Hubei Nordex Pharmaceutical Co., Ltd.

Heilongjiang Dina Pharmaceutical Co., Ltd.

Hebei Wansui Pharmaceutical Co., Ltd.

Guizhou Hanfang Pharmaceutical Co., Ltd.

Beijing Yadong Biopharmaceutical Co., Ltd.

Beijing Boran Pharmaceutical Co., Ltd.

Naoliqing Capsules Segment by Type

Boxed

Bottled

Naoliqing Capsules Segment by Application

Hospital

Clinic

Other

Naoliqing Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naoliqing Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naoliqing Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naoliqing Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Naoliqing Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Naoliqing Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Boxed Table 2. Major Company of Bottled Table 3. Global Naoliqing Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Naoliqing Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Naoliqing Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Naoliqing Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Naoliqing Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Naoliqing Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Naoliqing Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Naoliqing Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Naoliqing Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Naoliqing Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Naoliqing Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Naoliqing Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Naoliqing Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Naoliqing Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Naoliqing Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Naoliqing Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Naoliqing Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Naoliqing Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Naoliqing Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Naoliqing Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Naoliqing Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Naoliqing Capsules Industry Trends Table 25. Naoliqing Capsules Industry Drivers Table 26. Naoliqing Capsules Industry Opportunities and Challenges Table 27. Naoliqing Capsules Industry Restraints Table 28. Global Naoliqing Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Naoliqing Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Naoliqing Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Naoliqing Capsules Sales Share by Company (2021-2026) Table 32. Global Naoliqing Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Naoliqing Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Naoliqing Capsules Major Company Production Sites and Headquarters Table 35. Global Naoliqing Capsules Company, Product Type & Application Table 36. Global Naoliqing Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Naoliqing Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Naoliqing Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Naoliqing Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Naoliqing Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Naoliqing Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Naoliqing Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Naoliqing Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Naoliqing Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Naoliqing Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Naoliqing Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Naoliqing Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Naoliqing Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Naoliqing Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Naoliqing Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Naoliqing Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Naoliqing Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Naoliqing Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Naoliqing Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Naoliqing Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Naoliqing Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Naoliqing Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Naoliqing Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Naoliqing Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Naoliqing Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Naoliqing Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Naoliqing Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Naoliqing Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Naoliqing Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Naoliqing Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Naoliqing Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Naoliqing Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Xiuzhen Pharmaceutical Group Co., Ltd. Company Information Table 72. Xiuzhen Pharmaceutical Group Co., Ltd. Business Overview Table 73. Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Product Portfolio Table 75. Xiuzhen Pharmaceutical Group Co., Ltd. Recent Development Table 76. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information Table 77. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview Table 78. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 80. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Development Table 81. Tonghua Xindongri Pharmaceutical Co., Ltd. Company Information Table 82. Tonghua Xindongri Pharmaceutical Co., Ltd. Business Overview Table 83. Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 85. Tonghua Xindongri Pharmaceutical Co., Ltd. Recent Development Table 86. Shanxi Tiansheng Pharmaceutical Co., Ltd. Company Information Table 87. Shanxi Tiansheng Pharmaceutical Co., Ltd. Business Overview Table 88. Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 90. Shanxi Tiansheng Pharmaceutical Co., Ltd. Recent Development Table 91. Shanxi Yellow River Chinese Medicine Co., Ltd. Company Information Table 92. Shanxi Yellow River Chinese Medicine Co., Ltd. Business Overview Table 93. Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Product Portfolio Table 95. Shanxi Yellow River Chinese Medicine Co., Ltd. Recent Development Table 96. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Company Information Table 97. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Business Overview Table 98. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Product Portfolio Table 100. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Recent Development Table 101. Shanxi Huakang Pharmaceutical Co., Ltd. Company Information Table 102. Shanxi Huakang Pharmaceutical Co., Ltd. Business Overview Table 103. Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 105. Shanxi Huakang Pharmaceutical Co., Ltd. Recent Development Table 106. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information Table 107. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview Table 108. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 110. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Development Table 111. Jilin Zixin Pharmaceutical Co., Ltd. Company Information Table 112. Jilin Zixin Pharmaceutical Co., Ltd. Business Overview Table 113. Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 115. Jilin Zixin Pharmaceutical Co., Ltd. Recent Development Table 116. Jilin Yinok Pharmaceutical Co., Ltd. Company Information Table 117. Jilin Yinok Pharmaceutical Co., Ltd. Business Overview Table 118. Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 120. Jilin Yinok Pharmaceutical Co., Ltd. Recent Development Table 121. Jilin Tiantai Pharmaceutical Co., Ltd. Company Information Table 122. Jilin Tiantai Pharmaceutical Co., Ltd. Business Overview Table 123. Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 125. Jilin Tiantai Pharmaceutical Co., Ltd. Recent Development Table 126. Hubei Nordex Pharmaceutical Co., Ltd. Company Information Table 127. Hubei Nordex Pharmaceutical Co., Ltd. Business Overview Table 128. Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 130. Hubei Nordex Pharmaceutical Co., Ltd. Recent Development Table 131. Heilongjiang Dina Pharmaceutical Co., Ltd. Company Information Table 132. Heilongjiang Dina Pharmaceutical Co., Ltd. Business Overview Table 133. Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 135. Heilongjiang Dina Pharmaceutical Co., Ltd. Recent Development Table 136. Hebei Wansui Pharmaceutical Co., Ltd. Company Information Table 137. Hebei Wansui Pharmaceutical Co., Ltd. Business Overview Table 138. Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 140. Hebei Wansui Pharmaceutical Co., Ltd. Recent Development Table 141. Guizhou Hanfang Pharmaceutical Co., Ltd. Company Information Table 142. Guizhou Hanfang Pharmaceutical Co., Ltd. Business Overview Table 143. Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 145. Guizhou Hanfang Pharmaceutical Co., Ltd. Recent Development Table 146. Beijing Yadong Biopharmaceutical Co., Ltd. Company Information Table 147. Beijing Yadong Biopharmaceutical Co., Ltd. Business Overview Table 148. Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 150. Beijing Yadong Biopharmaceutical Co., Ltd. Recent Development Table 151. Beijing Boran Pharmaceutical Co., Ltd. Company Information Table 152. Beijing Boran Pharmaceutical Co., Ltd. Business Overview Table 153. Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 155. Beijing Boran Pharmaceutical Co., Ltd. Recent Development Table 156. North America Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Naoliqing Capsules Sales by Country (2021-2026) & (K Units) Table 158. North America Naoliqing Capsules Sales Market Share by Country (2021-2026) Table 159. North America Naoliqing Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Naoliqing Capsules Sales Market Share Forecast by Country (2027-2032) Table 161. North America Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Naoliqing Capsules Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Naoliqing Capsules Market Share by Country (2021-2026) Table 164. North America Naoliqing Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Naoliqing Capsules Market Share Forecast by Country (2027-2032) Table 166. Europe Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Naoliqing Capsules Sales by Country (2021-2026) & (K Units) Table 168. Europe Naoliqing Capsules Sales Market Share by Country (2021-2026) Table 169. Europe Naoliqing Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Naoliqing Capsules Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Naoliqing Capsules Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Naoliqing Capsules Market Share by Country (2021-2026) Table 174. Europe Naoliqing Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Naoliqing Capsules Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Naoliqing Capsules Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Naoliqing Capsules Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Naoliqing Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Naoliqing Capsules Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Naoliqing Capsules Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Naoliqing Capsules Market Share by Country (2021-2026) Table 184. Asia-Pacific Naoliqing Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Naoliqing Capsules Market Share Forecast by Country (2027-2032) Table 186. Latin America Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Naoliqing Capsules Sales by Country (2021-2026) & (K Units) Table 188. Latin America Naoliqing Capsules Sales Market Share by Country (2021-2026) Table 189. Latin America Naoliqing Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Naoliqing Capsules Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Naoliqing Capsules Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Naoliqing Capsules Market Share by Country (2021-2026) Table 194. Latin America Naoliqing Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Naoliqing Capsules Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Naoliqing Capsules Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Naoliqing Capsules Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Naoliqing Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Naoliqing Capsules Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Naoliqing Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Naoliqing Capsules Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Naoliqing Capsules Market Share by Country (2021-2026) Table 204. Middle East and Africa Naoliqing Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Naoliqing Capsules Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Naoliqing Capsules Distributors List Table 209. Naoliqing Capsules Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Naoliqing Capsules Image Figure 2. Global Naoliqing Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naoliqing Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Naoliqing Capsules Sales (2021-2032) & (K Units) Figure 5. Boxed Image Figure 6. Global Boxed Sales YoY Growth (2021-2032) & (K Units) Figure 7. Bottled Image Figure 8. Global Bottled Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Naoliqing Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Naoliqing Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Naoliqing Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Naoliqing Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Naoliqing Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Naoliqing Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Naoliqing Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Naoliqing Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Naoliqing Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Naoliqing Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Naoliqing Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Naoliqing Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Naoliqing Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Naoliqing Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Naoliqing Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Naoliqing Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Naoliqing Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Naoliqing Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Naoliqing Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Naoliqing Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Naoliqing Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Naoliqing Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Naoliqing Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Naoliqing Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Naoliqing Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Naoliqing Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Naoliqing Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Naoliqing Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Naoliqing Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Naoliqing Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Naoliqing Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Naoliqing Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Naoliqing Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Naoliqing Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Naoliqing Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Naoliqing Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Naoliqing Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Naoliqing Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Naoliqing Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Naoliqing Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Naoliqing Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Naoliqing Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Naoliqing Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Naoliqing Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Naoliqing Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Naoliqing Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Naoliqing Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Boxed
  • Bottled
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Xiuzhen Pharmaceutical Group Co., Ltd.
  • Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  • Tonghua Xindongri Pharmaceutical Co., Ltd.
  • Shanxi Tiansheng Pharmaceutical Co., Ltd.
  • Shanxi Yellow River Chinese Medicine Co., Ltd.
  • Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.
  • Shanxi Huakang Pharmaceutical Co., Ltd.
  • Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  • Jilin Zixin Pharmaceutical Co., Ltd.
  • Jilin Yinok Pharmaceutical Co., Ltd.
  • Jilin Tiantai Pharmaceutical Co., Ltd.
  • Hubei Nordex Pharmaceutical Co., Ltd.
  • Heilongjiang Dina Pharmaceutical Co., Ltd.
  • Hebei Wansui Pharmaceutical Co., Ltd.
  • Guizhou Hanfang Pharmaceutical Co., Ltd.
  • Beijing Yadong Biopharmaceutical Co., Ltd.
  • Beijing Boran Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Naoliqing Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Naoliqing Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Naoliqing Capsules Market by Type
  6. 1.3.1 Boxed
  7. 1.3.2 Bottled
  8. 1.4 Global Naoliqing Capsules Market Size by Type
  9. 1.4.1 Global Naoliqing Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Naoliqing Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Naoliqing Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Naoliqing Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Naoliqing Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Naoliqing Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Naoliqing Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Naoliqing Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Naoliqing Capsules Industry Trends
  2. 2.2 Naoliqing Capsules Industry Drivers
  3. 2.3 Naoliqing Capsules Industry Opportunities and Challenges
  4. 2.4 Naoliqing Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Naoliqing Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Naoliqing Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Naoliqing Capsules Price (2021-2026)
  4. 3.4 Global Naoliqing Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Naoliqing Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Naoliqing Capsules Company, Product Type & Application
  7. 3.7 Global Naoliqing Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Naoliqing Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Naoliqing Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Naoliqing Capsules Tier 1, Tier 2, and Tier 3
4 Naoliqing Capsules Regional Status and Outlook
  1. 4.1 Global Naoliqing Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Naoliqing Capsules Historic Market Size by Region
  3. 4.2.1 Global Naoliqing Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Naoliqing Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Naoliqing Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Naoliqing Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Naoliqing Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Naoliqing Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Naoliqing Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Naoliqing Capsules by Application
  1. 5.1 Naoliqing Capsules Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Naoliqing Capsules Market Size by Application
  6. 5.2.1 Global Naoliqing Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Naoliqing Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Naoliqing Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Naoliqing Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Naoliqing Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Naoliqing Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Naoliqing Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Naoliqing Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xiuzhen Pharmaceutical Group Co., Ltd.
  2. 6.1.1 Xiuzhen Pharmaceutical Group Co., Ltd. Company Information
  3. 6.1.2 Xiuzhen Pharmaceutical Group Co., Ltd. Business Overview
  4. 6.1.3 Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Product Portfolio
  6. 6.1.5 Xiuzhen Pharmaceutical Group Co., Ltd. Recent Developments
  7. 6.2 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  8. 6.2.1 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  12. 6.2.5 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Tonghua Xindongri Pharmaceutical Co., Ltd.
  14. 6.3.1 Tonghua Xindongri Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Tonghua Xindongri Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  18. 6.3.5 Tonghua Xindongri Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shanxi Tiansheng Pharmaceutical Co., Ltd.
  20. 6.4.1 Shanxi Tiansheng Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Shanxi Tiansheng Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  24. 6.4.5 Shanxi Tiansheng Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Shanxi Yellow River Chinese Medicine Co., Ltd.
  26. 6.5.1 Shanxi Yellow River Chinese Medicine Co., Ltd. Company Information
  27. 6.5.2 Shanxi Yellow River Chinese Medicine Co., Ltd. Business Overview
  28. 6.5.3 Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Product Portfolio
  30. 6.5.5 Shanxi Yellow River Chinese Medicine Co., Ltd. Recent Developments
  31. 6.6 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.
  32. 6.6.1 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Company Information
  33. 6.6.2 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Business Overview
  34. 6.6.3 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Product Portfolio
  36. 6.6.5 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Recent Developments
  37. 6.7 Shanxi Huakang Pharmaceutical Co., Ltd.
  38. 6.7.1 Shanxi Huakang Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shanxi Huakang Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  42. 6.7.5 Shanxi Huakang Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  44. 6.8.1 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  48. 6.8.5 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Jilin Zixin Pharmaceutical Co., Ltd.
  50. 6.9.1 Jilin Zixin Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Jilin Zixin Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  54. 6.9.5 Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Jilin Yinok Pharmaceutical Co., Ltd.
  56. 6.10.1 Jilin Yinok Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Jilin Yinok Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  60. 6.10.5 Jilin Yinok Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Jilin Tiantai Pharmaceutical Co., Ltd.
  62. 6.11.1 Jilin Tiantai Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Jilin Tiantai Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  66. 6.11.5 Jilin Tiantai Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Hubei Nordex Pharmaceutical Co., Ltd.
  68. 6.12.1 Hubei Nordex Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Hubei Nordex Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  72. 6.12.5 Hubei Nordex Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Heilongjiang Dina Pharmaceutical Co., Ltd.
  74. 6.13.1 Heilongjiang Dina Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Heilongjiang Dina Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  78. 6.13.5 Heilongjiang Dina Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Hebei Wansui Pharmaceutical Co., Ltd.
  80. 6.14.1 Hebei Wansui Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Hebei Wansui Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  84. 6.14.5 Hebei Wansui Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Guizhou Hanfang Pharmaceutical Co., Ltd.
  86. 6.15.1 Guizhou Hanfang Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Guizhou Hanfang Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  90. 6.15.5 Guizhou Hanfang Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Beijing Yadong Biopharmaceutical Co., Ltd.
  92. 6.16.1 Beijing Yadong Biopharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Beijing Yadong Biopharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  96. 6.16.5 Beijing Yadong Biopharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Beijing Boran Pharmaceutical Co., Ltd.
  98. 6.17.1 Beijing Boran Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Beijing Boran Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  102. 6.17.5 Beijing Boran Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Naoliqing Capsules Sales by Country
  2. 7.1.1 North America Naoliqing Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Naoliqing Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Naoliqing Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Naoliqing Capsules Market Size by Country
  6. 7.2.1 North America Naoliqing Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Naoliqing Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Naoliqing Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Naoliqing Capsules Sales by Country
  2. 8.1.1 Europe Naoliqing Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Naoliqing Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Naoliqing Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Naoliqing Capsules Market Size by Country
  6. 8.2.1 Europe Naoliqing Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Naoliqing Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Naoliqing Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Naoliqing Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Naoliqing Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Naoliqing Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Naoliqing Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Naoliqing Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Naoliqing Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Naoliqing Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Naoliqing Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Naoliqing Capsules Sales by Country
  2. 10.1.1 South America Naoliqing Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Naoliqing Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Naoliqing Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Naoliqing Capsules Market Size by Country
  6. 10.2.1 South America Naoliqing Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Naoliqing Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Naoliqing Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Naoliqing Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Naoliqing Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Naoliqing Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Naoliqing Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Naoliqing Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Naoliqing Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Naoliqing Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Naoliqing Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Naoliqing Capsules Value Chain Analysis
  2. 12.1.1 Naoliqing Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Naoliqing Capsules Production Mode & Process
  7. 12.2 Naoliqing Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Naoliqing Capsules Distributors
  10. 12.2.3 Naoliqing Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research